1. Introduction {#sec1-ijerph-17-05351}
===============

In 2019 it was estimated that about 3.5 million Italians (5.3% of the entire population) are living after a cancer diagnosis \[[@B1-ijerph-17-05351]\]. Improvements in medical treatments have led to a substantial increase in the proportion of cancer patients with death rates similar to those of the general Italian population \[[@B2-ijerph-17-05351]\].

Cancer and its treatments are associated with various side effects that negatively affect the patient's quality of life for a long time after the conclusion of therapies \[[@B3-ijerph-17-05351],[@B4-ijerph-17-05351]\]. There is growing evidence that in cancer patients (especially breast, colon and prostate) \[[@B5-ijerph-17-05351],[@B6-ijerph-17-05351],[@B7-ijerph-17-05351]\] an active lifestyle is associated with a lower risk of recurrence and mortality. Physical activity (PA) refers to any bodily movement produced by skeletal muscles that requires energy expenditure \[[@B8-ijerph-17-05351]\]. Exercise is defined as a subcategory of PA, consisting of structured, planned and repetitive movement \[[@B8-ijerph-17-05351]\]. Exercise was shown to be safe and feasible in oncological settings \[[@B9-ijerph-17-05351]\] and several studies found that exercise improved patients' quality of life during \[[@B10-ijerph-17-05351],[@B11-ijerph-17-05351]\] and after treatment \[[@B11-ijerph-17-05351]\]. Positive effects of exercise include increasing cardiorespiratory fitness \[[@B12-ijerph-17-05351]\] and muscular strength \[[@B13-ijerph-17-05351]\], and improvement in body composition \[[@B13-ijerph-17-05351]\]. Additionally, exercise helped regulate several side effects of cancer treatment, such as fatigue \[[@B14-ijerph-17-05351]\], and nausea \[[@B15-ijerph-17-05351]\], and improved the psychological status, for instance, reducing levels of anxiety and depression \[[@B16-ijerph-17-05351]\].

Despite the benefits related to PA and exercise, a large percentage of cancer patients from 25% to 84% are not sufficiently active \[[@B17-ijerph-17-05351],[@B18-ijerph-17-05351],[@B19-ijerph-17-05351]\] and the level of exercise has been seen to decrease after cancer diagnosis \[[@B20-ijerph-17-05351]\]. A multitude of factors influence the participation of the general population in exercise programs (e.g., lack of time, cost, logistic difficulties, etc.) \[[@B21-ijerph-17-05351]\]. Cancer patients face further obstacles on account of their condition (e.g., cancer-related fatigue, muscle weakness, nausea, sleep disorders) \[[@B22-ijerph-17-05351],[@B23-ijerph-17-05351]\]. To develop a successful exercise intervention, cancer patients' barriers and preferences must be considered, allowing them to pick the activities they perceive as beneficial and enjoyable \[[@B23-ijerph-17-05351],[@B24-ijerph-17-05351],[@B25-ijerph-17-05351],[@B26-ijerph-17-05351]\]. International studies investigated the preferences and determinants of exercise levels in cancer patients and survivors \[[@B18-ijerph-17-05351],[@B27-ijerph-17-05351],[@B28-ijerph-17-05351],[@B29-ijerph-17-05351],[@B30-ijerph-17-05351],[@B31-ijerph-17-05351],[@B32-ijerph-17-05351],[@B33-ijerph-17-05351]\], but data on the Italian population are lacking. Furthermore, cultural differences in this area might be significant. In order to overcome this information gap the STIP-ON (Sustainable training in pazienti oncologici) survey was designed with the following aims: (i) To understand the size of the problem, i.e., to calculate the prevalence of insufficient exercise among cancer patients; (ii) to analyze the patients' characteristics associated with insufficient exercise; (iii) to analyze the patients' characteristics associated with their motivation/willingness to take part in a future intervention program on exercise; (iv) to describe patients' preferences about exercise.

The rationale of the study is that understanding patients' preferences and barriers to physical activity will make it easier for them to participate successfully in a future intervention study to improve their physical fitness.

2. Materials and Methods {#sec2-ijerph-17-05351}
========================

2.1. Study Design and Participants {#sec2dot1-ijerph-17-05351}
----------------------------------

This STIP-ON study is a cross-sectional survey. Data were collected and recorded anonymously from patients visiting the cancer outpatients' facilities at the Oncology Unit of "Azienda Ospedaliera Universitaria Integrata", University of Verona, Verona, Italy between July 2018 and April 2019. Cancer patients' eligibility criteria were: age ≥18 years, a cancer diagnosis and adequate Italian language proficiency to answer the survey questionnaire (QEX). Invited participants included all kinds of cancer survivors (including those whose diagnosis had just been made or was being defined). The STIP-ON sample was thought to be representative of patients visiting the cancer outpatients' facilities: on randomly selected days they were approached face to face, informed about the study and asked whether they would be willing to complete the questionnaire anonymously to investigate their characteristics and preferences regarding exercise. Invited participants were systematically asked by the staff if they had already completed the survey another time/day before this QEX was administered. A duplicate check was done, looking for duplicates by date of birth, province of residence, sex, education, and marital status. If interested in participating, patients were asked to give signed informed consent, and received a leaflet ([Supplementary Material 1](#app1-ijerph-17-05351){ref-type="app"}) describing the purpose of the study and a copy of QEX. QEX was completed on the spot or could be taken home and returned within a week. In both cases, participants were asked to leave the completed QEX anonymously in a special 'ballot box'.

The project was reviewed and approved by the Ethics Committee for Clinical Trials (Prot. No. 49018), University of Verona. All study procedures were conducted following the last revision of the declaration of Helsinki as well as the declaration of Oviedo. The study protocol was designed to adhere to Good Clinical Practice principles and procedures and had to comply with Italian legislation.

2.2. The Survey Questionnaire (QEX) {#sec2dot2-ijerph-17-05351}
-----------------------------------

The QEX is a self-administered survey to collect cancer patients' preferences and characteristics associated with exercise. The questionnaire is the result of a co-design process that involved patients (via patients' associations) and experts, including oncologists, kinesiologists, epidemiologists and psycho-oncologists. The pilot version of QEX was developed based on a literature review \[[@B27-ijerph-17-05351],[@B28-ijerph-17-05351],[@B29-ijerph-17-05351],[@B30-ijerph-17-05351],[@B31-ijerph-17-05351]\] made available to these 'reviewers' to give feedbacks and make an unofficial peer review to develop the current version. While QEX is a self-reported, anonymous survey, staff support (including dedicated personnel in the room) was available during the survey to address any questions. The QEX comprises 31 items (Q1--Q31), divided into four sections: (a) General characteristics (from Q1 to Q9); (b) Physical exercise level (from Q10 to Q11); (c) Physical exercise preferences (from Q12 to Q26); (d) Cancer diagnosis and treatment (from Q27 to Q31). A copy of QEX is available online as [Supplementary Material 2](#app1-ijerph-17-05351){ref-type="app"}.

### 2.2.1. Questions 1--9: General Characteristics {#sec2dot2dot1-ijerph-17-05351}

The following demographic, anthropometric and socio-economic characteristics of patients are collected in the QEX: birth date (day, month, year), sex, province of residence, education level (elementary---up to age 10--11 years/secondary---up to 14 years/secondary---up to 18--19 years/college--university/postgraduate), marital status (single/married/divorced/widowed, occupational status (retired/homemaker/part-time employed/full-time employed/other), perceived economic adequacy (inadequate/barely adequate/adequate/more than adequate), body weight (kg) and height (cm) (both continuous). Age was calculated by subtracting the date of birth from the date of QEX compilation and classified in two categories (\<65; ≥65y). Body mass index (BMI) was calculated from the weight in kilograms divided by the height in meters squared (kg/m^2^). BMI categories were defined as follows: underweight (BMI \<18.5 kg/m^2^), normal weight (BMI 18.5--24.9 kg/m^2^); overweight (BMI 25--29.9 kg/m^2^); obese (\>29.9 kg/m^2^) \[[@B34-ijerph-17-05351]\].

### 2.2.2. Questions 10--11: Level of Physical Exercise {#sec2dot2dot2-ijerph-17-05351}

The QEX inquiry about current exercise level was based on questions from the Godin Leisure-Time Exercise Questionnaire (GLTEQ) \[[@B35-ijerph-17-05351]\] which is widely used for cancer patients \[[@B36-ijerph-17-05351]\]. A detailed description of the computation of LSI from GLTEQ is found elsewhere \[[@B35-ijerph-17-05351],[@B36-ijerph-17-05351]\]. In brief: (i) The GLTEQ enquires about the previous week's leisure time frequency (times/week) of vigorous, moderate- and mild-intensity exercise; (ii) Each exercise intensity is associated with the metabolic equivalent of the task (MET): MET = 9 for vigorous, MET = 5 for moderate, MET = 3 for mild intensity exercise \[[@B35-ijerph-17-05351]\]; (iii) The LSI is then calculated as the sum of (vigorous × 9) + (moderate × 5) per-week exercise frequency according to Godin and Shepard \[[@B35-ijerph-17-05351]\]. Based on their LSI, patients are classified as active (if LSI ≥24) or insufficiently active (if LSI \<24) according to the 2010 release of American College of Sports Medicine (ACSM) Exercise Guidelines for cancer patients \[[@B37-ijerph-17-05351]\]. The ACSM guidelines suggest cancer patients engage in at least 150 min/week of moderate or 75 min/week of vigorous exercise \[[@B37-ijerph-17-05351]\]. The QEX includes an additional self-rated question about the frequency (times/week) of sweat-inducing activity. There are three categories of frequency (often/sometime/never--rarely) these questions and categorization are also taken from GLTEQ \[[@B35-ijerph-17-05351]\].

### 2.2.3. Questions 12--26: Physical Exercise Preferences {#sec2dot2dot3-ijerph-17-05351}

Exercise preferences were investigated by questions from previous studies \[[@B27-ijerph-17-05351],[@B28-ijerph-17-05351],[@B29-ijerph-17-05351],[@B30-ijerph-17-05351],[@B31-ijerph-17-05351]\]. The first question concerns the patient's willingness to participate in an exercise program (yes/no/maybe). Respondents were asked about their preference regarding: who would give them exercise instructions (oncologist/nurse/kinesiologist/nutritionist/physiotherapist/another cancer patient/no preference/other); how to receive exercise instructions (face to face/by telephone/videotape/television/brochure-pamphlet/over the internet/no preference/other); with whom they would prefer to exercise (nobody/other cancer patients/family members/friends/a group/no preference/other); where (at home/at a community fitness center/at an adapted exercise fitness center/outside/no preference/other); what time of day (morning/afternoon/evening/no preference); what part of the week (weekday/weekend/no preference) and how often (from never to seven times/week). Further information was collected on preferred intensity (mild/moderate/strenuous/no preference), session content variability (same each time/different each time/no preference), "helper" during the program (nobody/exercise specialist/neighbor/colleague/friend/son-daughter/spouse/other relative), supervision (unsupervised/supervised/no preference) and kind of exercise program (individual with a program to follow at home/individual with personal trainer/in a group with a kinesiologist/physiotherapist/exercise specialist). There were also two open-ended questions in which respondents were encouraged to list the top three preferred exercise activities in winter and summer.

### 2.2.4. Questions 27--31: Cancer Diagnosis and Treatment {#sec2dot2dot4-ijerph-17-05351}

Medical variables were self-reported by patients and included: tumor site (lung/colorectal/breast/head-neck/upper gastrointestinal/gynecological/urogenital/melanoma/ hematological/other), disease status (unknown/in remission-cured/early/advanced/metastatic), date of diagnosis (month/year), type of treatment (surgery/chemotherapy/radiotherapy/hormone therapy/other) and current treatment status (about to start/ongoing/completed/not known).

Time from diagnosis was calculated by subtracting the date of diagnosis from the date of QEX compilation and was classified in two categories using the median (≤30 months; \>30 months).

2.3. Statistical Analysis {#sec2dot3-ijerph-17-05351}
-------------------------

Descriptive analyses are presented as mean, medians and IQR for continuous variables and frequencies and percentages for categorical variables. Categorical non-ordinal variables were incorporated as dummy variables (Xd) in regression models so that Xd = 1 if the condition is true and Xd = 0 if not. Minimally adjusted models to investigate patients' characteristics associated with willingness to participate and current exercise level included age and sex as explanatory variables. Multivariable regression models to investigate patients' characteristics associated with their willingness to participate and current exercise level included explanatory variables, selected in advance, in the fiducial model that subsequently maximized the goodness of fit, according to the Akaike information criterion (AIC) \[[@B38-ijerph-17-05351]\]. These variables included: sex, age, education, residence, perceived income adequacy, marital status, occupational status, frequency of sweat-inducing activity, tumor site, disease, chemotherapy, surgery, radiotherapy, hormone therapy, other treatments, treatment status, time from diagnosis, "lack of preference" (score 0 for no no-preference reply, score 1 for 1 no-preference reply, score 2 for 2 or more no-preference replies to exercise preference questions), "independence" (score 0 if "on my own" never chosen in exercise preference questions, score 1 otherwise).

The sample size of 200 cancer patients was based on the feasibility criteria of the study. The expected sample allowed estimates of binary variables \[e.g., percentages of active (*p*) vs. percentages of insufficiently active (*P* = 1 − *p*) or percentages of patients expressing interest vs. percentages expressing no strong interest\] with a standard error of 0.035 and a confidence interval between 0.43 and 0.57, assuming the most unfavorable proportion equal to 0.5 (*P* = 0.5) and alpha 5%.

Statistical tests were two-sided and *p* values \< 0.05 were considered significant. The Stata statistical package, version 14 (Stata Corp, Texas, TX, USA) was used.

3. Results {#sec3-ijerph-17-05351}
==========

The flow diagram of participants is shown in [Figure 1](#ijerph-17-05351-f001){ref-type="fig"}. Among the 694 patients approached, 249 (36%) declined to participate in the survey. The most frequent reason for declining was lack of interest. Among the 445 who agreed to participate, 53 did not return the QEX, leaving the final study sample of 392 subjects (55% of the patients approached).

3.1. General and Tumor Characteristics {#sec3dot1-ijerph-17-05351}
--------------------------------------

Demographic and medical variables stratified by the willingness to participate in the exercise program are set out in [Table 1](#ijerph-17-05351-t001){ref-type="table"}. The participants' mean age was 59.6 ± 12.2 y, 61% were female, 69% were married and 61% had at least higher education, up to age 18--19 years. Overall, 83% of participants were still on active treatment; the most frequent tumor sites were upper gastro-intestine (42%) and breast (26%), with a mean time from diagnosis of 2.4 years.

3.2. Exercise Behavior {#sec3dot2-ijerph-17-05351}
----------------------

Details on participants' exercise behavior by sex and age are shown in [Table 2](#ijerph-17-05351-t002){ref-type="table"}. Patients reported mean frequencies of strenuous, moderate and mild exercise of 0.2 ± 0.84; 0.71 ± 1.43 and 1.56 ± 2.15 times/week respectively. The LSI found 93% of patients insufficiently active, and only 7% met physical activity recommendations \[[@B33-ijerph-17-05351]\]. Men and women reported similar exercise behavior through age. Older patients (≥65 years) reported a decline in strenuous and moderate exercise frequencies and an increase in mild exercise compared to \<65 years.

3.3. Exercise Preferences {#sec3dot3-ijerph-17-05351}
-------------------------

Participants exercise preferences are listed in [Table 3](#ijerph-17-05351-t003){ref-type="table"}. Overall, 80% of the respondents were willing (i.e., yes or maybe) to participate in an exercise program designed for cancer patients. Over half (57%) preferred to receive exercise instructions from an oncologist, about 30% from a physiotherapist and 20% from a kinesiologist. The preferred way to receive exercise instructions was with a face-to-face approach (72%), followed by no preferences (12%). The people they preferred to exercise with were other cancer patients (27%). The favorite place for exercise was outside (27%), followed by an adapted exercise fitness center (22%) or at home (21%). Almost half (48%) indicated they preferred exercising in the morning and 70% preferred exercising during a weekday. Just over a third (37%) opted to exercise twice a week and another 30% three times a week. Walking, swimming and biking were the favored activities in summer, while in winter participants opted for walking, gym training and swimming. Participants also specified that they preferred training at mild (48%) or moderate (39%) intensity. About 34% of patients preferred exercise sessions to vary. Most of them (62%) preferred supervised exercise. The preferred helpers were spouses (28%), exercise specialists (22%) or friends (19%). The preferred exercise program was in a group with an expert (40%).

3.4. Relations between Demographic/Medical Variables within Exercise Behavior and Willingness to Participate in Exercise Program {#sec3dot4-ijerph-17-05351}
--------------------------------------------------------------------------------------------------------------------------------

[Table 4](#ijerph-17-05351-t004){ref-type="table"} shows the relations between characteristics of cancer patients willing to participate the exercise program. Multivariable logistic regression models showed that these patients most likely attended at least secondary school beyond age 14 years (OR = 1.87, 95% CI = 1.15 to 3.04) and had more than double the sweat-inducing activity per week (OR = 1.92, 95% CI = 1.92 to 3.63). Among medical treatments, patients who received chemotherapy were less willing to participate (OR = 0.45, 95% CI = 0.23 to 0.86) than those who did not.

[Table 5](#ijerph-17-05351-t005){ref-type="table"} shows how patients' characteristics were related to current exercise levels. Levels were lower in patients with BMI ≥25 (β = −0.33, 95% CI −0.57 to −0.10) than those with BMI \<25. Exercise levels were higher in patients who had attended at least secondary school beyond age 14 years (β = 0.32, 95% CI 0.09 to 0.55) compared with those with less than secondary school. Patients who self-defined their disease stage as "advanced" had lower exercise levels (β −0.36, 95% CI −0.75 to −0.02) than those in remission/cured.

4. Discussion {#sec4-ijerph-17-05351}
=============

The STIP-ON survey found that only 7% of cancer patients do enough physical exercise. Previous studies reported the percentage of cancer patients with adequate exercise levels, between 16--85% \[[@B17-ijerph-17-05351]\]. Considering the impact of physical inactivity on the quantity \[[@B5-ijerph-17-05351],[@B6-ijerph-17-05351],[@B7-ijerph-17-05351]\] and quality \[[@B10-ijerph-17-05351],[@B11-ijerph-17-05351]\] of life in cancer patients this is an alarming result.

Roughly 80% of patients were willing to start an exercise program designed for cancer patients. Previous studies reported similar results, finding that the majority of bladder \[[@B39-ijerph-17-05351]\], non-Hodgkin's lymphoma \[[@B29-ijerph-17-05351]\], prostate \[[@B27-ijerph-17-05351]\], head and neck \[[@B31-ijerph-17-05351]\], endometrial \[[@B28-ijerph-17-05351]\], ovarian \[[@B30-ijerph-17-05351]\] and breast \[[@B27-ijerph-17-05351]\] cancer survivors were interested in an exercise program. This is important because it supports the cancer patients' desire for an exercise service.

Several socio-demographic characteristics were associated with the willingness to participate in an exercise program. Willingness decreased with age, also in fully adjusted models, and this was to be expected given the growing difficulties and comorbidities due to aging. Age has been associated with low adherence to exercise in cancer patients in various studies \[[@B30-ijerph-17-05351],[@B40-ijerph-17-05351]\]. What is interesting is that, even among the older patients, more than two-thirds said they might be interested in taking part in an exercise program. Women were more willing to participate than men. That was found in all models, even after adjustment for medical and socio-demographic variables. That women cancer patients adhere better than men in exercise programs is suggested by an intervention study in rectal cancer patients \[[@B40-ijerph-17-05351]\] although a systematic review evaluating the predictors of adherence to exercise interventions during cancer treatment suggested that adherence was best among men \[[@B41-ijerph-17-05351]\]. Better-educated patients were more willing to participate. This was reported in other studies, too \[[@B30-ijerph-17-05351],[@B42-ijerph-17-05351]\], and a likely explanation is well-educated people's greater awareness and knowledge of the benefits of exercise. It is interesting that economic security was not related to the willingness to participate, and that too was suggested by other studies \[[@B40-ijerph-17-05351]\]. This lack of association might be the result of two concomitant and opposing phenomena: those who have less financial availability willingly accept a free offer to exercise; the same poorer people, however, may have less desire to exercise because they are less motivated or because they do manual work. Patients who reported higher frequencies of sweat-inducing activity were more willing to participate in an exercise program that those less frequently reporting it. This can be summed up with the Italian saying: "it rains where it's already wet"; in other words, those who are most motivated are those who would need it less. No similar results were found in the literature, but a possible explanation is that those who have already done more physical exercise perceive the benefits better and are therefore more ready to improve or increase their level \[[@B43-ijerph-17-05351]\]. Chemotherapy was inversely associated with the willingness to participate. There is one study that found no relation between cancer treatment and adherence in high-intensity and low-to-moderate-intensity exercises \[[@B42-ijerph-17-05351]\]; other studies found chemotherapy \[[@B41-ijerph-17-05351]\] and its side effects \[[@B22-ijerph-17-05351]\] were associated with low adherence to physical exercise programs. One explanation for these contradictory results may be that chemotherapy is a generic term that includes different drugs and various possible side effects. There were no differences in willingness to participate based on other medical variables, and this is consistent with previous work on this topic \[[@B30-ijerph-17-05351]\].

Regarding the preferred source of exercise instruction, the oncologist was the preferred person to deliver instructions in the present survey and this is not in line with the current standard of care. Previous investigations reported an exercise expert (kinesiologist) as the favorite \[[@B17-ijerph-17-05351]\]. Findings from the present survey may be related to the lack of exercise specialists for patients at the Verona Hospital Oncology Unit. The trusting relationship between the patient and the oncologist built up during the cancer journey is another likely explanation. Less than half of oncologists promote exercise with their patients \[[@B44-ijerph-17-05351]\]. Barriers that interfere with exercise promotion by oncologists were identified as lack of time, limited access to an exercise specialist/program and lack of knowledge about exercise in cancer \[[@B45-ijerph-17-05351]\]. However, educational sessions about exercise in cancer patients and caregivers, specific education materials (leaflets, brochures, posters, etc.) and/or a kinesiologist as part of the clinical team are recognized factors to help promote exercise \[[@B45-ijerph-17-05351]\].

Social support plays a role in exercise program compliance \[[@B46-ijerph-17-05351]\]. In the oncological setting, social support enhances emotional well-being \[[@B47-ijerph-17-05351]\] and is related to PA engagement \[[@B48-ijerph-17-05351]\]. The present results are in line with this: 55% of patients preferred exercise with others (cancer patients, relatives, friends); about 87% expressed interest in having a helper, i.e., a person to help and motivate them with the exercise, identifying various subjects: the spouse or other relatives, or exercise specialists. Social support from different helpers has been seen to be effective for behavior change \[[@B49-ijerph-17-05351]\]: family, friends, peers, exercise specialists, healthcare providers, and other influential subjects might be the key figures to support compliance and the maintenance of exercise over time \[[@B50-ijerph-17-05351]\].

Although in previous studies there was a marked preference for a home-based program \[[@B17-ijerph-17-05351],[@B27-ijerph-17-05351],[@B28-ijerph-17-05351],[@B30-ijerph-17-05351],[@B39-ijerph-17-05351]\], in this study similar percentages of patients preferred exercising outside, or in an adapted exercise fitness center, or at home. This suggests that providing different program options would boost compliance for exercise interventions. To reinforce this assumption, subjects were asked what they would choose out of three exercise options (individually with a program to follow at home/individually in a gym with a kinesiologist/in a group class with a kinesiologist/none of these). More than 90% indicated their preference among these options.

The majority of STIP-ON participants preferred a supervised exercise program. This finding contrasts with studies on bladder \[[@B39-ijerph-17-05351]\], head and neck \[[@B31-ijerph-17-05351]\], prostate and breast \[[@B27-ijerph-17-05351]\] cancer, but is in line with other investigations on mixed \[[@B51-ijerph-17-05351]\], lung \[[@B52-ijerph-17-05351]\] and endometrial \[[@B28-ijerph-17-05351]\] cancers. One explanation might be related to the patients' health condition: cancer-related treatments affect normal physical function and influence daily activities, hence the need for supervision from a qualified figure to avoid adverse effects. Moreover, supervised exercise intervention may give additional benefits for cancer patients. A recent metanalysis including a total of 4519 patients with mixed cancer types evaluated the effect of exercise on quality of life and physical function; it found twice the effect size for supervised compared to unsupervised training \[[@B53-ijerph-17-05351]\].

In line with previous studies \[[@B27-ijerph-17-05351],[@B28-ijerph-17-05351],[@B30-ijerph-17-05351],[@B31-ijerph-17-05351],[@B39-ijerph-17-05351],[@B51-ijerph-17-05351]\], a substantial proportion of patients indicated walking as their favorite activity, in winter and summer. Walking programs have been effective to manage treatment side effects and improve physical functions in cancer populations \[[@B54-ijerph-17-05351],[@B55-ijerph-17-05351]\]. Walking is relatively safe, flexible and easy as it does not require special skills \[[@B56-ijerph-17-05351]\]. Moreover, walking can be done in different environmental situations, is accessible and appropriate in groups of different age, sex, ethnicity, education or income levels, and does not require expensive equipment. Walking is also known to reduce social barriers among people of different socio-economics status \[[@B57-ijerph-17-05351]\].

Contrary to other reports \[[@B27-ijerph-17-05351],[@B28-ijerph-17-05351],[@B31-ijerph-17-05351],[@B51-ijerph-17-05351],[@B52-ijerph-17-05351]\], the present study indicated the preferred exercise intensity as mild. Exercise guidelines for cancer patients suggest they should engage in at least moderate exercise \[[@B58-ijerph-17-05351]\]. Mild intensity could be the choice to start an exercise program, especially with physically 'deconditioned' people, and should be gradually increased to moderate and vigorous intensity. Several reviews show moderate-to-vigorous but not mild exercise intensity is effective in managing cancer side effects, and improves physical function \[[@B14-ijerph-17-05351],[@B59-ijerph-17-05351]\].

In light of this evidence, the present findings highlight the need to inform cancer patients and their caregivers about the safety of moderate and vigorous intensities exercise. Patients' exercise levels were related to their educational level, type of treatment and body fatness. Several studies have investigated the determinants and triggers of exercise behaviors in patients, but with inconsistent findings \[[@B60-ijerph-17-05351],[@B61-ijerph-17-05351],[@B62-ijerph-17-05351]\].

This appears to be the first study investigating the determinants of exercise preferences in Italian cancer patients before they were involved in exercise intervention programs. The study results provide useful data for planning future exercise programs. The self-reported QEX permitted the collection of a large amount of data and was quickly administered, without much burden on respondents, or costs. Another point of strength is the collection of information about why individuals did not wish to take part in the study.

Limitations of the study need to be noted: the QEX information was self-reported and therefore open to several sources of bias. The QEX was filled and returned anonymously, so social desirability bias (for instance, patients may exaggerate their physical activity so as not to 'disappoint' the researcher) is less likely. The information leaflet given to patients at recruitment provides minimal information presenting the study but does not contain any recommendations/guidelines. However, just having provided information might have influenced the replies. Another potential source of error is selection bias: cancer patients who agreed to participate in the survey may be individuals more interested in exercise. To ensure a representative sample of patients, a random sample of outpatients was selected. Finally, the questionnaire does not serve to classify exercise adherence according to the new ACSM \[[@B58-ijerph-17-05351]\] guidelines for cancer patients. These guidelines were released in October 2019, after the QEX had been administered to the study sample of patients \[[@B58-ijerph-17-05351]\]. Nevertheless, the QEX classifies patients according to the previous ACSM guidelines \[[@B37-ijerph-17-05351]\]. This allows us to compare patients' exercise levels with the studies that have been reported so far. Classification of the LSI according to the ACSM guidelines for cancer patients \[[@B37-ijerph-17-05351]\] allows a full comparison of study finding with the majority of other studies in the field. Nevertheless, this classification may have artificially inflated the percentage of participants who reported insufficient physical activity. The QEX does not collect information about participants' pre-diagnosis exercise and physical activity and that limit its ability to explore associations with other possible determinants of current exercise behavior. The patients in STIP-ON were sampled to be representative of those attending the Verona oncology clinic (and not the full total of patients). Therefore, although more severe patients with severe comorbidities are likely to have been excluded, patients' responses may also have been influenced by other comorbidities that were not investigated by the QEX.

Information from this survey is clinically relevant and may help in designing personalized interventions so cancer patients will achieve sufficient exercise/PA. Here are a few examples: (i) Since about 90% of participants said they wanted or needed a helper during the program, a targeted intervention program should include specific activities (and support) for helpers patients will nominate; (ii) Because about 30% of respondents said they prefer to exercise with other patients, exercise classes specifically for them and "learning from peers" social occasions should be organized; (iii) The majority of patients were insufficiently active and preferred mild exercise or slow walking. So as not to leave anyone behind, for those who are not able to engage in moderate exercise, a mild flexible entry program should be offered according the patient's condition and preferences and then progress slowly towards higher-intensity exercise.

5. Conclusions {#sec5-ijerph-17-05351}
==============

In conclusion, an exploratory survey like STIP-ON could serve as a necessary first step in developing lifestyle improvement interventions for patients. This is particularly important in a country like Italy where there is little knowledge in this field, and factors such as the family environment and social support are not well understood. Only a small proportion of patients were sufficiently active, although the majority were willing to start an exercise program. Exercise preferences in cancer patients tended to vary substantially. These findings underline the urgency of promoting personalized exercise intervention programs among Italian cancer patients.

S.P. is supported by the Italian Association for Cancer Research AIRC-IG 20583. S.P. was supported by the International Association for Lung Cancer (IASLC).

The following are available online at <https://www.mdpi.com/1660-4601/17/15/5351/s1>, **SM1:** Information leaflet for patients; **SM2:** Questionnaire to collect cancer patient's preferences and characteristics associated with exercise

###### 

Click here for additional data file.

Conceptualization, A.A., V.P. and M.L. Methodology, A.A., V.K. and V.P. Formal Analysis, A.A., M.B. and V.P. Investigation, A.A. Resources, A.A., V.K. and V.P. Data Curation, A.A. and V.P. Writing---Original Draft Preparation, A.A. and V.P. Writing---Review & Editing, A.A., V.P., I.T., D.T., L.M., S.S., V.K., M.B., M.M., S.P., M.L. Visualization, A.A., V.P., I.T., D.T., L.M., S.S., V.K., M.B., M.M., S.P., M.L. Supervision, M.M., S.P., M.L., V.P. Project Administration, A.A., M.M., S.P., M.L. All authors have read and agreed to the published version of the manuscript.

This research received no external funding.

M.M. reports personal fees from Pfizer, EUSA Pharma and Astra Zeneca. S.P. received honoraria or speakers' fees from Astra-Zeneca, Eli-Lilly, BMS, Boehringer Ingelheim, MSD, Roche and Istituto Gentili. All remaining authors have declared no conflicts of interest.

![Flow of participants through the study.](ijerph-17-05351-g001){#ijerph-17-05351-f001}

ijerph-17-05351-t001_Table 1

###### 

General and tumor characteristics of 392 cancer patients^†^ according to willingness to participate in a specifically designed exercise program.

                                       All   Willingness to Participate ^‡^   *p*-Value ^§^                        
  ------------------------------------ ----- -------------------------------- --------------- ---- ----- ---- ---- -------
  **Age** (years)                                                                                                  
  \<65                                 239   48                               115             38   91    14   33   0.023
  ≥65                                  149   42                               63              28   41    30   45   
  **Sex**                                                                                                          
  Female                               238   51                               121             32   77    17   40   0.023
  Male                                 154   38                               58              37   57    25   39   
  **Province of residence**                                                                                        
  Verona                               244   43                               105             34   82    23   57   0.114
  Other                                148   50                               74              35   52    15   22   
  **Education**                                                                                                    
  Elementary (up to 10--11 years)      32    28                               9               28   9     44   14   0.002
  Secondary (up to 14 years)           119   41                               49              37   44    22   26   0.451
  Secondary (up to 18--19 years)       162   50                               80              36   59    14   22   0.031
  College/University                   52    54                               28              25   13    21   11   0.308
  Postgraduate                         18    50                               9               33   6     17   3    0.920
  **Body Mass Index ^¶^**                                                                                          
  Underweight                          19    58                               11              32   6     11   2    0.455
  Normal weight                        228   46                               104             34   78    20   46   0.994
  Overweight                           107   41                               44              36   39    22   24   0.503
  Obese                                30    57                               17              27   8     17   5    0.461
  **Marital status**                                                                                               
  Single                               51    43                               22              35   18    22   11   0.903
  Married                              269   45                               122             35   94    20   53   0.819
  Divorced                             35    46                               16              34   12    20   7    0.999
  Widowed                              34    56                               19              24   8     21   7    0.371
  **Occupational status**                                                                                          
  Retired                              161   46                               74              30   48    24   39   0.151
  Homemaker                            43    44                               19              30   13    26   11   0.622
  Part-time employed                   45    49                               22              42   19    9    4    0.118
  Full-time employed                   123   46                               57              38   47    15   19   0.242
  Other                                20    35                               7               35   7     30   6    0.462
  **Perceived income adequacy ^††^**                                                                               
  Inadequate                           28    50                               14              36   10    14   4    0.746
  Barely adequate                      120   45                               54              40   48    15   18   0.152
  Adequate                             180   44                               80              34   61    22   39   0.676
  More than adequate                   61    51                               31              23   14    26   16   0.103
  **Exercise level ^‡‡^**                                                                                          
  Insufficiently active                363   45                               162             35   127   20   75   0.338
  Active                               27    59                               16              26   7     15   4    
  **Tumor site**                                                                                                   
  Breast                               101   54                               55              31   31    15   15   0.096
  Lung                                 22    41                               9               36   8     23   5    0.894
  Colorectum                           39    31                               12              49   19    21   8    0.091
  Head/neck                            9     44                               4               22   2     33   3    0.554
  Upper gastro-intestine               166   46                               77              35   58    19   31   0.821
  Gynecological                        8     50                               4               38   3     13   1    0.862
  Urogenital                           19    53                               10              21   4     26   5    0.450
  Melanoma                             14    21                               3               29   4     50   7    0.015
  Other                                14    36                               5               36   5     29   4    0.659
  **Disease status**                                                                                               
  Unknown                              53    40                               21              32   17    28   15   0.274
  In remission/cured                   62    56                               35              27   17    16   10   0.178
  Early                                86    48                               41              37   32    15   13   0.411
  Advanced                             85    38                               32              40   34    22   19   0.239
  Metastatic                           106   47                               50              32   34    21   22   0.866
  **Treatments ^§§^**                                                                                              
  Surgery                              215   44                               95              32   69    24   51   0.167
  Chemotherapy                         329   44                               144             36   119   20   66   0.102
  Radiation therapy                    113   44                               50              29   33    27   30   0.119
  Hormone therapy                      50    56                               28              30   15    14   7    0.249
  Other                                27    59                               16              19   5     22   6    0.190
  **Treatment status**                                                                                             
  About to start                       11    55                               6               27   3     18   2    0.829
  Ongoing                              325   44                               144             35   115   20   66   0.452
  Completed                            35    51                               18              29   10    20   7    0.728
  Unknown                              21    52                               11              29   6     19   4    0.804
  **Time from diagnosis**                                                                                          
  ≤30 months                           178   48                               86              37   65    15   27   0.080
  ≥30 months                           214   43                               93              32   69    24   52   

^†^ Participants of STIP-ON study conducted in Verona, Italy, from July 2018 to April 2019. ^‡^ Willingness to participate in exercise program assessed by the question: Would you be interested in participating in an exercise program designed for cancer patients? ^§^ Pearson's chi-squared used the null hypotheses of no association between physical exercise level and other patient/disease characteristics. ^¶^ Body Mass Index categories are those of the World Health Organization \[[@B34-ijerph-17-05351]\]. ^††^ Perceived income adequacy assessed by the question: Does your monthly income cover your monthly expenditure? ^‡‡^ Exercise level according to Leisure Score Index (LSI). Patients are active if LSI ≥24 and insufficiently active if LSI \<24 \[[@B36-ijerph-17-05351]\]. ^§§^ Treatments, which may be completed or in course, and are not mutually exclusive.
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###### 

Characteristics of preceding week's exercise in cancer patients† by age and sex.

  Exercise Frequency (Times/Week) by Intensity ^‡^   All Patients   Age \< 65 Years   Age ≥ 65 Years                                                      
  -------------------------------------------------- -------------- ----------------- ---------------- -------- ------- -------- ------- -------- ------- ----
  Strenuous                                          0.20           0                 0.21             0        0.29    0        0.13    0        0.08    0
  (0.84)                                             \(0\)          (0.85)            \(0\)            (1.03)   \(0\)   (0.70)   \(0\)   (0.42)   \(0\)   
  Moderate                                           0.71           0                 0.64             0        0.77    0        0.61    0        0.75    0
  (1.43)                                             \(1\)          (1.30)            \(1\)            (1.40)   \(1\)   (1.53)   \(0\)   (1.53)   \(1\)   
  Mild                                               1.56           0                 1.20             0        1.31    0        2.24    2        1.68    0
  (2.15)                                             \(2\)          (1.68)            \(2\)            (1.99)   \(2\)   (2.49)   \(4\)   (2.38)   \(3\)   
  **Exercise level ^††^**                            N              \%                N                \%       N       \%       N       \%       N       \%
  Insufficiently active                              363            93                76               94       144     92       66      94       74      95
  Sufficiently active                                27             7                 5                6        13      8        4       6        4       5
  **Sweat-inducing activity ^‡^**                    N              \%                N                \%       N       \%       N       \%       N       \%
  Often                                              60             16                9                11       23      15       15      21       13      17
  Sometimes                                          121            32                28               35       54      35       16      23       21      27
  Rarely/never                                       204            53                43               54       77      50       39      56       43      56

^†^ Participants of STIP-ON study conducted in Verona, Italy, from July 2018 to April 2019. ^‡^ Exercise intensity according to \[[@B35-ijerph-17-05351]\]. ^§^ SD, standard deviation; ^¶^ IQR, interquartile range. ^††^ Exercise level according to Leisure Score Index (LSI): active ≥24; insufficiently active \<24 \[[@B36-ijerph-17-05351]\].
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###### 

Exercise preferences in cancer patients ^†^.

  Preference as Expressed by Answers to Questions                                                      \%    No.
  ---------------------------------------------------------------------------------------------------- ----- -----
  **Are you interested in participating in an exercise program designed for cancer patients? (392)**         
  Yes                                                                                                  46    179
  No                                                                                                   20    79
  Maybe                                                                                                34    134
  **Who would you prefer to receive exercise instructions from? (392) ^‡^**                                  
  Oncologist                                                                                           57    224
  Nurse                                                                                                7     26
  Kinesiologist                                                                                        20    80
  Nutritionist                                                                                         20    80
  Physiotherapist                                                                                      30    118
  Another cancer patient                                                                               3     11
  No preference                                                                                        20    79
  Other                                                                                                2     8
  **How would you prefer to receive exercise instructions? (376)**                                           
  Face to face                                                                                         72    270
  By telephone                                                                                         3     13
  Videotape                                                                                            2     9
  Television                                                                                           1     3
  Leaflet/pamphlet                                                                                     5     20
  Over the internet                                                                                    3     13
  No preference                                                                                        12    46
  Other                                                                                                1     2
  **Where would you prefer to exercise? (378)**                                                              
  At home                                                                                              21    78
  At a community fitness center                                                                        12    44
  At an adapted exercise fitness center                                                                22    83
  Outside                                                                                              27    103
  No preference                                                                                        18    70
  Other                                                                                                1     2
  **What time of day would you prefer to exercise? (376)**                                                   
  Morning                                                                                              48    179
  Afternoon                                                                                            31    118
  Evening                                                                                              9     32
  No preference                                                                                        13    48
  **In what part of the week would you prefer to exercise? (367)**                                           
  Weekday                                                                                              70    256
  Weekend                                                                                              9     32
  No preference                                                                                        22    79
  **How would you prefer to exercise? (363)**                                                                
  Unsupervised                                                                                         15    56
  Supervised                                                                                           62    224
  No preference                                                                                        23    83
  **What kind of exercise program would you prefer? (360)**                                                  
  Individual with a program to follow at home                                                          27    96
  Individual with personal trainer                                                                     25    90
  In a group with a kinesiologist/physiotherapist/exercise specialist                                  40    144
  Other                                                                                                8     30
  **Would you like session content to vary? (363)**                                                          
  Same each time                                                                                       29    105
  Different each time                                                                                  34    123
  No preference                                                                                        37    135
  **Who would you prefer to exercise with? (373)**                                                           
  Nobody                                                                                               16    61
  Other cancer patients                                                                                27    104
  Family members                                                                                       8     29
  Friends                                                                                              8     30
  A group                                                                                              13    47
  No preference                                                                                        27    101
  Other                                                                                                1.3   5
  **Who would you want as "helper" during the program? (369)**                                               
  Nobody                                                                                               13    48
  Exercise specialist                                                                                  22    83
  Neighbor                                                                                             1     5
  Colleague                                                                                            1     3
  Friend                                                                                               19    71
  Son/daughter                                                                                         13    47
  Spouse                                                                                               28    102
  Other relative                                                                                       3     10
  **How often would you prefer to exercise? (365)**                                                          
  Never                                                                                                1     5
  Once a week                                                                                          15    54
  Twice a week                                                                                         37    136
  Three times a week                                                                                   30    111
  Four times a week                                                                                    5     19
  Five times a week                                                                                    5     19
  Six times a week                                                                                     1     5
  Seven times a week                                                                                   4     16
  **What exercise intensity would you prefer? (376)**                                                        
  Mild                                                                                                 48    175
  Moderate                                                                                             39    141
  Strenuous                                                                                            7     24
  No preference                                                                                        6     23

^†^ Participants of STIP-ON study conducted in Verona, Italy, from July 2018 to April 2019 ^‡^ Replies add up to more than 694 as participants could choose more than one instructor.
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###### 

Multivariable logistic modeling of associations of characteristics of cancer patients ^†^ with willingness ^‡^ to participate in an exercise program.

                                         All (No.)                        Willing to Participate (No.)   Minimally-Adjusted Model ^§^   Fully-Adjusted Model ^¶^                                             
  -------------------------------------- -------------------------------- ------------------------------ ------------------------------ -------------------------- ------- ------------ ------------ ------- --
  Age                                    ≤65 y (reference)                239                            115                            1                                               1                    
  ≥65y                                   149                              63                             0.84                           0.55; 1.28                 0.424   0.63         0.34; 1.15   0.085   
  Sex                                    Women (reference)                238                            121                            1                                               1                    
  Men                                    154                              58                             0.61                           0.40; 0.93                 0.021   0.55         0.32; 0.94   0.029   
  Education                              Up to age 14 years (reference)   151                            58                             1                                               1                    
  Beyond age 14 years                    241                              121                            1.60                           1.04; 2.46                 0.031   1.87         1.15; 3.04   0.011   
  Residence                              Outside city (Reference)         148                            74                             1                                               1                    
  In Verona                              244                              105                            0.70                           0.46; 1.07                 0.100   0.61         0.38; 0.99   0.045   
  Perceived income adequacy              Inadequate (reference)           148                            68                             1                                               1                    
  Adequate                               244                              111                            1.06                           0.69; 1.61                 0.764   0.94         0.58; 1.51   0.785   
  Marital status                         Married (reference)              269                            122                            1                                               1                    
  Single                                 51                               22                             0.77                           0.41; 1.44                 0.366   0.64         0.31; 1.31   0.213   
  Divorced                               35                               16                             0.92                           0.45; 1.89                 0.94    0.43; 2.01                        
  Widowed                                34                               19                             1.88                           0.85; 4.16                 2.51    1.04; 6.04                        
  Occupational status                    Retired (reference)              161                            74                             1                                               1                    
  Homemaker                              43                               19                             0.66                           0.31; 1.33                 0.354   0.73         0.33; 1.61   0.203   
  Part-time employed                     45                               22                             0.83                           0.37; 1.62                 0.67    0.30; 1.50                        
  Full-time employed                     123                              57                             0.83                           0.46; 1.43                 0.68    0.36; 1.29                        
  Other                                  20                               7                              0.52                           0.17; 1.33                 0.58    0.18; 1.90                        
  Frequency of sweat-inducing activity   \<1 time/week (reference)        204                            84                             1                                               1                    
  1--2 times/week                        121                              61                             1.46                           0.92; 2.32                 0.037   1.50         0.91; 2.25   0.035   
  \>2 times/week                         60                               33                             1.79                           1.00; 3.23                 1.92    1.92; 3.63                        
  Tumor site ^§§,¶¶^                     Breast (reference)               101                            55                             1                                               1                    
  Lung                                   22                               9                              0.60                           0.24; 1.58                 0.251   0.52         0.16; 1.68   0.423   
  Colorectal                             39                               12                             0.39                           0.18; 0.86                 0.46    0.18; 1.16                        
  Upper gastro-intestine                 166                              77                             0.73                           0.44; 1.20                 0.62    0.31; 1.24                        
  Urogenital system                      19                               10                             1.00                           0.37; 2.75                 1.02    0.28; 3.67                        
  Melanoma                               14                               3                              0.23                           0.06; 0.88                 0.13    0.03; 0.64                        
  Other sites^6^                         31                               13                             0.66                           0.29; 1.51                 0.52    0.20; 1.40                        
  Disease status                         Remission (reference)            62                             35                             1                                               1                    
  Early                                  86                               41                             0.70                           0.36; 1.36                 0.145   0.61         0.27; 1.37   0.595   
  Advanced                               85                               32                             0.48                           0.25; 0.95                 0.65    0.29; 1.44                        
  Metastatic                             106                              50                             0.71                           0.37; 1.44                 0.72    0.30; 1.73                        
  Unknown                                53                               21                             0.51                           0.24; 1.08                 0.83    0.33; 2.06                        
  Chemotherapy                           No (reference)                   55                             31                             1                                               1                    
  Yes                                    329                              144                            0.51                           0.28; 0.92                 0.026   0.45         0.23; 0.86   0.016   
  Surgery                                No (reference)                   169                            80                             1                                               1                    
  Yes                                    215                              95                             0.91                           0.60; 1.37                 0.644   1.07         0.67; 1.71   0.787   
  Radiotherapy                           No (reference)                   271                            125                                                                                                 
  Yes                                    113                              50                             0.90                           0.57; 1.41                 0.650   0.97         0.58; 1.61   0.900   
  Hormone therapy                        No (reference)                   334                            147                                                                                                 
  Yes                                    50                               28                             1.45                           0.78; 2.71                 0.239   1.66         0.83; 3.32   0.152   
  Other treatments                       No (reference)                   365                            163                                                                                                 
  Yes                                    27                               16                             2.10                           0.92; 4.82                 0.077   1.89         0.81; 4.39   0.142   
  Treatment status                       Completed (reference)            36                             18                             1                                               1                    
  About to start                         11                               6                              1.46                           0.36; 5.84                 0.695   1.80         0.31; 10.5   0.781   
  Ongoing                                325                              144                            0.79                           0.37; 1.60                 0.75    0.33; 1.71                        
  Unknown                                21                               11                             1.27                           0.42; 3.83                 1.72    0.45; 6.48                        
  Time from diagnosis                    ≤30 months (reference)           178                            86                             1                                               1                    
  \>30 months                            214                              93                             0.79                           0.53; 1.19                 0.265   0.68         0.42; 1.13   0.126   

^†^ Participants of STIP-ON study conducted in Verona, Italy, from July 2018 to April 2019 ^‡^ Willingness classified as yes vs. no/maybe. ^§^ Age- and sex-adjusted models, unless otherwise specified. ^¶^ Each variable adjusted for the following, unless otherwise specified: Sex (man vs. woman); Age (\<65 y vs. ≥65 y); Education (more than 14 years of age vs. up to 14 years); Residence (outside city vs. win city of Verona); Perceived income adequacy (adequate vs. inadequate); Marital status (married, single, divorced, widowed); Occupational status (retired, homemaker, part-time employed, full-time employed, other); Frequency of sweat-inducing activity (\<1 time/week, 1--2 times/week, \>2 times/week); Tumor site (breast, lung, colorectum, upper gastro-intestine, urogenital system, melanoma, other); Disease status (in remission, early, advanced, metastatic, unknown); Chemotherapy (yes vs. no); Surgery (yes vs. no); Radiotherapy (yes vs. no); Hormone therapy (yes vs. no); Other treatments (yes vs. no); Treatment status (Completed, About to start, Ongoing, Unknown); Time from diagnosis (≤30 months, \>30 months); "Lack of preference" variable (score 0 for no no-preference reply, score 1 for 1 no-preference reply, score 2 for 2 or more no-preference replies given to exercise preference questions); "Independence" variable (score 0 if "on my own" never chosen in exercise preference questions, score1 otherwise. ^††^ OR (odds ratios), CI (confidence intervals), and *p*-values from multivariable logistic regression model. ^§§^ Tumor sites with less than 10 patients are classified as "other site." ^¶¶^ Models investigating tumor site (both minimally and fully adjusted models) were not adjusted for sex.
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###### 

Multivariable regression modeling of associations of characteristics of 392 cancer patients ^†^ with exercise level ^‡^.

                              No.                              Exercise Level ^†^   Minimally-Adjusted Model ^§^   Fully-Adjusted Model ^¶^                                                                            
  --------------------------- -------------------------------- -------------------- ------------------------------ -------------------------- -------------- ------------- -------------- -------------- ------------- -------
  Age                         \<65 y (reference)               238                  0.61                           1.14                       Ref                                         Ref                          
                              ≥65y                             148                  0.42                           0.91                       −0.17          −0.39; 0.05   0.125          0.03           −0.24; 0.31   0.801
  Sex                         Female (reference)               237                  0.58                           1.10                       Ref                                         Ref                          
                              Male                             153                  0.46                           0.99                       −0.10          −0.32; 0.12   0.378          −0.08          −0.32; 0.16   0.489
  Body Mass Index (kg/m^2^)   \<25 (reference)                 245                  0.67                           1.21                       Ref                                         Ref                          
  ≥25                         137                              0.31                 0.71                           −0.34                      −0.57; −0.11   0.003         −0.33          −0.57; −0.10   0.005         
  Education                   Up to age 14 years (reference)   149                  0.32                           0.75                       Ref                                         Ref                          
  Beyond age 14 years         241                              0.67                 1.19                           0.32                       0.10; 0.55     0.004         0.32           0.09; 0.55     0.005         
  Perceived income adequacy   Inadequate (reference)           147                  0.52                           1.14                       Ref                                         Ref                          
  Adequate                    243                              0.55                 1.01                           0.06                       −0.16; 0.28    0.581         0.03           −0.20; 0.25    0.826         
  Marital status              Married (reference)              275                  0.53                           1.00                       Ref                                         Ref                          
  Single/other                51                               0.63                 1.15                           0.04                       −0.28; 0.37    0.86          −0.05          −0.39; 0.28    0.781         
  Divorced                    35                               0.63                 1.52                           0.08                       −0.30; 0.46    0.01          −0.37; 0.39                                 
  Widowed                     34                               0.41                 0.90                           −0.06                      −0.46; 0.34    −0.07         −0.47; 0.34                                 
  Occupation                  Retired (reference)              160                  0.38                           0.83                       Ref                                         Ref                          
  Homemaker                   43                               0.40                 0.87                           −0.05                      −0.42; 0.33    0.048         0.02           −0.37; 0.41    0.073         
  Part-time employed          45                               0.66                 1.14                           0.19                       −0.14; 0.62    0.24          −0.16; 0.64                                 
  Full-time employed          123                              0.76                 1.34                           0.37                       0.07; 0.66     0.32          −0.01; 0.62                                 
  Other                       19                               0.38                 0.74                           −0.01                      −0.53; 0.51    0.09          −0.48; 0.66                                 
  Tumor site ^‡‡^             Breast (reference)               101                  0.63                           1.27                       Ref                                         Ref                          
  Lung                        22                               0.09                 0.33                           −0.49                      −0.97; 0.02    0.579         −0.52          −1.05; 0.01    0.926         
  Colorectum                  39                               0.32                 0.94                           −0.30                      −0.67; 0.12    −0.33         −0.76; 0.10                                 
  Upper gastro-intestine      164                              0.59                 1.02                           −0.02                      −0.29; 0.24    −0.03         −0.36; 0.31                                 
  Urogenital system           19                               0.39                 0.94                           −0.18                      −0.70; 0.35    −0.26         −0.82; 0.31                                 
  Melanoma                    14                               0.79                 1.10                           0.17                       −0.43; 0.76    0.04          −0.61; 0.68                                 
  Other site ^§§^             31                               0.53                 0.92                           −0.15                      −0.51; 0.34    −0.18         −0.65; 0.30                                 
  Disease status              Remission (reference)            62                   0.85                           1.25                       Ref                                         Ref                          
  Early                       85                               0.73                 1.31                           −0.10                      −0.44; 0.25    0.006         0.15           −0.24; 0.54    0.010         
  Advanced                    84                               0.30                 0.82                           −0.51                      −0.86; −0.15   −0.36         −0.75; −0.02                                
  Metastatic                  106                              0.50                 0.97                           −0.30                      −0.63; 0.03    −0.28         −0.59; 0.08                                 
  Unknown                     53                               0.31                 0.69                           −0.49                      −0.87; −0.10   −0.43         −0.81; 0.03                                 
  Chemotherapy                No (reference)                   55                   0.56                           1.05                       Ref                                         Ref                          
  Yes                         327                              0.54                 1.07                           −0.06                      0.36; 0.25     0.720         0.04           −0.34; 0.38    0.914         
  Surgery                     No (reference)                   167                  0.48                           0.98                       Ref                                         Ref                          
  Yes                         215                              0.58                 1.12                           0.10                       −0.12; 0.31    0.366         0.07           −0.16; 0.31    0.540         
  Radiotherapy                No (reference)                   269                  0.55                           1.10                       Ref                                         Ref                          
  Yes                         113                              0.50                 0.97                           −0.03                      −0.26; 0.21    0.833         −0.10          −0.36; 0.16    0.454         
  Hormone therapy             No (reference)                   332                  0.53                           1.07                       Ref                                         Ref                          
  Yes                         50                               0.58                 1.00                           −0.01                      −0.34; 0.32    0.955         0.10           −0.26; 0.46    0.581         
  Other treatments            No (reference)                   363                  0.53                           1.05                       Ref                                         Ref                          
  Yes                         27                               0.60                 1.10                           0.09                       −0.33; 0.51    0.682         0.10           −0.37; 0.57    0.684         
  Treatment status            Completed (reference)            35                   0.83                           1.31                       Ref                                         Ref                          
  About to start              11                               0.54                 1.62                           −0.20                      −0.93; 0.53    0.184         0.18           −0.67; 1.04    0.462         
  Ongoing                     323                              0.50                 1.00                           −0.30                      −0.67; 0.07    −0.14         −0.54; 0.26                                 
  Unknown                     21                               0.54                 1.08                           −0.21                      −0.79; 0.37    −0.08         −0.72; 0.55                                 
  Time from diagnosis         ≤30 months (reference)           177                  0.47                           0.94                       Ref                                         Ref                          
  \>30 months                 213                              0.59                 1.15                           0.13                       −0.08; 0.34    0.225         0.15           −0.08; 0.39    0.207         

^†^ Participants of STIP-ON study conducted in Verona, Italy, from July 2018 to April 2019 ^‡^ Exercise level assessed using Leisure Score Index \[[@B36-ijerph-17-05351]\]. ^§^ Age and sex adjusted models unless otherwise specified. ^¶^ Each variable was adjusted for the following, unless otherwise specified: Sex (man vs. woman); Age (\<65y vs. ≥65y); Education (beyond 14 years of age vs. up to 14 years); Residence (outside city vs. in city of Verona); Perceived income adequacy (adequate vs. inadequate); Marital status (married, single, divorced, widow); Occupational status (retired, homemaker, part-time employed, full-time employed, other); Tumor site (breast, lung, colorectum, upper gastro-intestine, urogenital system, melanoma, other); Disease status (remission, early, advanced, metastatic, unknown); Chemotherapy (yes vs. no); Surgery (yes vs. no); Radiotherapy (yes vs. no); Hormone therapy (yes vs. no); Other treatments (yes vs. no); Treatment status (completed, about to start, ongoing, unknown); Time from diagnosis (≤30 months vs. 30 months). ^††^ Beta coefficients 9 (β), confidence intervals (CI), and *p* values from multivariable regression models. The β coefficient is the amount of change in exercise level (Leisure Score Index) in each category of predictor variable compared to reference. ^‡‡^ Minimally and fully adjusted models for tumor site not adjusted for sex. ^§§^ Tumor sites with \<10 patients classified with another site.
